Xeris Pharmaceuticals Inc (XERS)

Xeris Pharmaceuticals Inc (XERS) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2B; returns 1 day -6.1%, 1 week -1.1%, 1 year +11.7%.

Xeris Biopharma Holdings, Inc. (XERS) is a biopharmaceutical company specializing in innovative formulations of peptide and protein therapeutics using its proprietary XeriSol and XeriJect technologies for subcutaneous and oral delivery.

Groups XERS belongs to

• Biopharmaceutical
• Commercial Stage
• Commercial Stage Biotech
• Healthcare
• Pharmaceuticals
• Endocrinology
• Rare Diseases
• Biotechnology
• Life Sciences
• Metabolic Disorders

XERS financial model: income statement, cash flow and balance sheet